Additional file 1: of Long-term adverse event profile from four completed trials of oral eliglustat in adults with Gaucher disease type 1 [stub]

M. Peterschmitt, Selena Freisens, Lisa Underhill, Meredith Foster, Grace Lewis, Sebastiaan Gaemers
2019 Figshare  
Table S1. Adverse events causing study discontinuation. Table S2. Cardiac adverse events reported by at least 2 patients in the pooled adverse events analysis (0.5% or more of total trials population). Table S3. Serious cardiac events. (PDF 127 kb)
doi:10.6084/m9.figshare.8244914.v1 fatcat:s2jepd4hofc4tetia6hdp5b3gm